CDMO Avid Bioservices, Inc. Stock Quote

CDMO [NASD]

Index	-	P/E	141.09	EPS (ttm)	0.13	Insider Own	0.30%	Shs Outstand	61.41M	Perf Week	-12.25%
Market Cap	1.14B	Forward P/E	56.00	EPS next Y	0.33	Insider Trans	-29.50%	Shs Float	60.77M	Perf Month	-33.65%
Income	8.30M	PEG	9.41	EPS next Q	0.04	Inst Own	96.30%	Short Float	9.64%	Perf Quarter	-29.57%
Sales	106.30M	P/S	10.72	EPS this Y	120.80%	Inst Trans	-0.63%	Short Ratio	5.73	Perf Half Y	-29.84%
Book/sh	0.83	P/B	21.93	EPS next Y	21.27%	ROA	3.30%	Target Price	32.67	Perf Year	27.72%
Cash/sh	2.61	P/C	6.96	EPS next 5Y	15.00%	ROE	12.80%	52W Range	12.60 - 34.51	Perf YTD	-37.63%
Dividend	-	P/FCF	142.48	EPS past 5Y	31.60%	ROI	7.00%	52W High	-47.26%	Beta	2.45
Dividend %	-	Quick Ratio	2.70	Sales past 5Y	16.70%	Gross Margin	32.90%	52W Low	44.44%	ATR	1.50
Employees	252	Current Ratio	3.00	Sales Q/Q	-43.90%	Oper. Margin	15.40%	RSI (14)	22.12	Volatility	6.20% 6.26%
Optionable	Yes	Debt/Eq	2.77	EPS Q/Q	-32.60%	Profit Margin	7.80%	Rel Volume	0.67	Prev Close	18.51
Shortable	Yes	LT Debt/Eq	2.77	Earnings	Dec 07 AMC	Payout	0.00%	Avg Volume	1.02M	Price	18.20
Recom	2.00	SMA20	-26.35%	SMA50	-34.65%	SMA200	-26.20%	Volume	680,189	Change	-1.67%

Dec-08-21

Downgrade

KeyBanc Capital Markets

Overweight → Sector Weight

Mar-17-21

Initiated

RBC Capital Mkts

Outperform

$21

Nov-10-20

Initiated

KeyBanc Capital Markets

Overweight

$12

Dec-10-19

Upgrade

First Analysis Sec

Outperform → Strong Buy

Oct-17-19

Initiated

Stephens

Overweight

Oct-16-19

Initiated

Craig Hallum

Buy

$11

Jun-28-19

Upgrade

Janney

Neutral → Buy

$10

May-09-19

Downgrade

Janney

Buy → Neutral

Jan-21-22 06:15PM	Avid Bioservices (CDMO) Stock Moves -1.67%: What You Should Know Zacks
Jan-14-22 11:22AM	Avid Bioservices, Inc. (CDMO) Fell Out Of Favor With Hedge Funds? Insider Monkey
Jan-10-22 08:05AM	Avid Bioservices Announces Official Opening of Second Downstream Processing Suite Within Myford North Facility GlobeNewswire
Jan-07-22 01:38PM	Future Financial Wealth Managment LLC Buys The Energy Select Sector SPDR Fund, Global X U.S. ... GuruFocus.com
Dec-30-21 04:51AM	Zacks Investment Ideas feature highlights: Gilead Sciences, Regeneron and Avid Bioservices Zacks
Dec-29-21 02:16PM	Follow The Leader: 3 Biopharma Stocks Displaying Relative Strength Zacks
Dec-21-21 06:41AM	Avid Bioservices (CDMO) Sees Hammer Chart Pattern: Time to Buy? Zacks
Dec-15-21 10:00AM	Avid Bioservices (CDMO) Loses 24.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Zacks
Dec-09-21 11:55AM	10 Stocks Making Headlines After Financial Results Insider Monkey
Dec-08-21 03:14AM	Avid Bioservices (CDMO) Tops Q2 Earnings and Revenue Estimates Zacks
Dec-07-21 11:30PM	Avid Bioservices, inc (CDMO) Q2 2022 Earnings Call Transcript Motley Fool
04:05PM	Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2021 and Recent Developments GlobeNewswire
Dec-06-21 11:32AM	15 Best Stocks to Buy for 2022 According to Analysts Insider Monkey
04:39AM	While shareholders of Avid Bioservices (NASDAQ:CDMO) are in the black over 5 years, those who bought a week ago aren't so fortunate Simply Wall St.
Dec-03-21 11:58AM	7 A-Rated Biotechs to Buy for the Long Run InvestorPlace -8.22%
Dec-02-21 07:26PM	The Cooper Companies (COO) Q4 Earnings Lag Estimates Zacks
Nov-30-21 04:05PM	Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2022 After Market Close on December 7, 2021 GlobeNewswire
Nov-24-21 03:00PM	Avid Bioservices (CDMO) Earnings Expected to Grow: What to Know Ahead of Q2 Release Zacks
Nov-04-21 08:05AM	Avid Bioservices Appoints Elie G. Hanania, Ph.D., as Vice President, Process Development, Viral Vector Technologies GlobeNewswire
Oct-26-21 06:39PM	Why Avid Bioservices Stock Surged 14% Today Motley Fool +14.00%
08:05AM	Avid Bioservices to Join S&P SmallCap 600 Index GlobeNewswire
Oct-25-21 06:58PM	Avid Bioservices Set to Join S&P SmallCap 600 PR Newswire
05:13PM	Here is What Hedge Funds Think About Avid Bioservices, Inc. (CDMO) Insider Monkey
Oct-14-21 08:05AM	Avid Bioservices Announces Expansion into Viral Vector Development and Manufacturing Services for Cell and Gene Therapy GlobeNewswire +5.98%
Oct-07-21 08:05AM	Avid Bioservices Appoints Matthew Kwietniak as Chief Commercial Officer GlobeNewswire
06:44AM	Is Avid Bioservices, Inc.'s (NASDAQ:CDMO) 29% ROE Better Than Average? Simply Wall St.
Oct-01-21 09:33AM	Reata (RETA) Confirms Omaveloxolone NDA Filing in Q1 2022 Zacks
Sep-14-21 10:00AM	Down 20.1% in 4 Weeks, Here's Why Avid Bioservices (CDMO) Looks Ripe for a Turnaround Zacks
Sep-09-21 03:00PM	Avid Bioservices, inc (CDMO) Q1 2021 Earnings Call Transcript Motley Fool -12.05%
Sep-08-21 04:05PM	Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2021 and Recent Developments GlobeNewswire
Sep-02-21 04:05PM	Avid Bioservices to Participate at Upcoming Investor Conferences GlobeNewswire
Sep-01-21 04:05PM	Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2022 After Market Close on September 8, 2021 GlobeNewswire
Aug-08-21 03:59AM	We Think Avid Bioservices (NASDAQ:CDMO) Can Manage Its Debt With Ease Simply Wall St.
Jul-29-21 12:19PM	Is Avid Bioservices (CDMO) A Great Long-Term Investment? Insider Monkey
Jul-20-21 09:27AM	Hedge Funds Arent Crazy About Avid Bioservices, Inc. (CDMO) Anymore Insider Monkey
Jul-01-21 08:05AM	Avid Bioservices Announces Appointment of Esther M. Alegria, Ph.D., to Board of Directors GlobeNewswire
Jun-29-21 07:00PM	Avid Bioservices, Inc. (CDMO) Q4 2021 Earnings Call Transcript Motley Fool
04:05PM	Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2021 and Recent Developments GlobeNewswire
Jun-24-21 02:05AM	Breakeven On The Horizon For Avid Bioservices, Inc. (NASDAQ:CDMO) Simply Wall St.
Jun-22-21 04:05PM	Avid Bioservices to Report Financial Results For Quarter and Fiscal Year Ended April 30, 2021 After Market Close on June 29, 2021 GlobeNewswire
03:00PM	Avid Bioservices (CDMO) Q4 Earnings Preview: What's in the Cards? Zacks
Jun-04-21 04:36AM	Avid Bioservices (CDMO) Stock Jumps 7.2%: Will It Continue to Soar? Zacks
May-25-21 08:05AM	Avid Bioservices to Serve as Commercial Manufacturer for ADC Therapeutics ZYNLONTA (Loncastuximab Tesirine-Lpyl) GlobeNewswire
May-21-21 09:55AM	Omeros' (OMER) BLA for Narsoplimab Gets Extended Review Zacks
Apr-27-21 10:31AM	Avid Bioservices' (CDMO) Shares March Higher, Can It Continue? Zacks
Apr-25-21 04:20AM	Announcing: Avid Bioservices (NASDAQ:CDMO) Stock Soared An Exciting 755% In The Last Five Years Simply Wall St.
Apr-22-21 05:54PM	Is CDMO Stock A Buy or Sell? Insider Monkey +5.59%
Apr-15-21 04:05PM	Avid Bioservices Announces Completion of Redemption of Series E Convertible Preferred Stock GlobeNewswire
Apr-14-21 09:40AM	Geron (GERN) Begins Phase III Myelofibrosis Study on Imetelstat Zacks
Apr-07-21 08:29AM	5 Stocks to Buy on New Analyst Coverage Zacks
Apr-06-21 09:57AM	Avid Bioservices' (CDMO) Shares March Higher, Can It Continue? Zacks
Mar-23-21 09:24AM	Zacks.com featured highlights include: UFP Industries, Interactive Brokers Group, Avid Bioservices, Amtech Systems and Gaia Zacks
Mar-22-21 09:02AM	These 5 Stocks Are Safe Bets Courtesy of New Analyst Coverage Zacks
Mar-17-21 08:05AM	Avid Bioservices to Participate in KeyBanc Capital Markets Life Sciences & MedTech Investor Forum GlobeNewswire
Mar-12-21 06:01AM	Avid Bioservices (CDMO) Sees Hammer Chart Pattern: Time to Buy? Zacks
Mar-10-21 12:20AM	Avid Bioservices, Inc. Announces Pricing of $125 Million Offering of Exchangeable Senior Notes GlobeNewswire
Mar-08-21 07:00PM	Avid Bioservices, Inc. (CDMO) Q3 2021 Earnings Call Transcript Motley Fool
05:35PM	Avid Bioservices (CDMO) Surpasses Q3 Earnings and Revenue Estimates Zacks
05:01PM	Avid Bioservices, Inc. Announces Proposed $125 Million Offering of Exchangeable Senior Notes GlobeNewswire
04:31PM	Avid Bioservices: Q3 Earnings Insights Benzinga
04:05PM	Avid Bioservices Reports Financial Results for Third Quarter Fiscal 2021 and Recent Developments GlobeNewswire
01:30PM	Avid Bioservices, Inc. to Host Earnings Call ACCESSWIRE
Mar-03-21 04:05PM	Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock GlobeNewswire
Mar-01-21 04:05PM	Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2021 After Market Close on March 8, 2021 GlobeNewswire +5.78%
Feb-23-21 11:57PM	Do Institutions Own Avid Bioservices, Inc. (NASDAQ:CDMO) Shares? Simply Wall St.
02:49PM	Pacira Pharmaceuticals Getting Closer To Key Technical Measure Investor's Business Daily
Feb-22-21 08:05AM	Avid Bioservices Begins Phase 2 of its Myford Manufacturing Capacity Expansion Plan GlobeNewswire
Feb-18-21 01:08PM	Inovio Pharmaceuticals Shows Market Leadership With Jump To 86 RS Rating Investor's Business Daily
Feb-03-21 07:00AM	Humanigen and Avid Bioservices Enter into cGMP Manufacturing Agreement for COVID-19 Therapeutic Candidate Lenzilumab in Support of Potential EUA Filing GlobeNewswire
07:00AM	Humanigen and Avid Bioservices Enter Into cGMP Manufacturing Agreement for COVID-19 Therapeutic Candidate Lenzilumab in Support of Potential EUA Filing Business Wire
Jan-26-21 11:21AM	Is Avid Bioservices (CDMO) Stock a Buy For 2021? Insider Monkey
Jan-10-21 01:55AM	Have Insiders Been Buying Avid Bioservices, Inc. (NASDAQ:CDMO) Shares This Year? Simply Wall St.
Dec-15-20 08:51PM	Is CDMO A Good Stock To Buy Now? Insider Monkey
Dec-14-20 04:05PM	Avid Bioservices Announces Closing of Public Offering of Common Stock GlobeNewswire
Dec-10-20 09:00AM	Avid Bioservices Announces Pricing of Public Offering of Common Stock GlobeNewswire
Dec-09-20 04:45PM	Avid Bioservices Announces Proposed Public Offering of Common Stock GlobeNewswire
Dec-07-20 04:05PM	Avid Bioservices Announces Appointment of Jeanne Thoma to Board of Directors GlobeNewswire
01:57PM	Sarepta Therapeutics Earns Relative Strength Rating Upgrade Investor's Business Daily
Dec-05-20 01:36AM	Avid Bioservices, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates Simply Wall St.
Dec-03-20 11:03AM	Why Avid Bioservices Stock Is Soaring Today Motley Fool +16.42%
Dec-02-20 09:30PM	Avid Bioservices, Inc. (CDMO) Q2 2021 Earnings Call Transcript Motley Fool +8.20%
04:19PM	Recap: Avid Bioservices Q2 Earnings Benzinga
04:05PM	Avid Bioservices Reports Financial Results for Second Quarter Fiscal 2021 and Recent Developments GlobeNewswire
02:45PM	Avid Bioservices, Inc. to Host Earnings Call ACCESSWIRE
Dec-01-20 04:05PM	Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock GlobeNewswire
Nov-24-20 04:05PM	Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2021 After Market Close on December 2, 2020 GlobeNewswire
Nov-08-20 08:20AM	Are Investors Undervaluing Avid Bioservices, Inc. (NASDAQ:CDMO) By 44%? Simply Wall St.
Nov-05-20 10:00AM	Bristol-Myers Squibb (BMY) Catches Eye: Stock Jumps 6.8% Zacks
Sep-24-20 09:29AM	Is Avid Bioservices' (NASDAQ:CDMO) Share Price Gain Of 135% Well Earned? Simply Wall St.
Sep-15-20 04:05PM	Avid Bioservices Announces Move to Virtual-Only Annual Meeting of Stockholders on October 20, 2020 GlobeNewswire
Sep-10-20 10:29AM	Avid Bioservices (CDMO) Has Risen 37% in Last One Year, Outperforms Market Insider Monkey
08:05AM	Avid Bioservices to Participate in 18th Annual Morgan Stanley Global Healthcare Conference GlobeNewswire
Sep-03-20 07:55AM	The Daily Biotech Pulse: Sanofi, GSK Begin Phase 1/2 Coronavirus Vaccine Study, Fulgent Strikes COVID-19 Testing Deal, New Data From Novavax Benzinga -12.06%
Sep-02-20 07:25AM	The Daily Biotech Pulse: Amarin's Vascepa Appeal Hearing, Avid Bioservices' Strong Q1, A Life Sciences Blank Check IPO Benzinga
Sep-01-20 06:30PM	Avid Bioservices, Inc. (CDMO) Q1 2021 Earnings Call Transcript Motley Fool
04:18PM	Recap: Avid Bioservices Q1 Earnings Benzinga
04:05PM	Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2020 and Recent Developments GlobeNewswire
Aug-31-20 04:05PM	Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock GlobeNewswire
10:15AM	Avid Bioservices Earnings Preview Benzinga
Aug-26-20 08:05AM	Avid Bioservices Selected by Mapp Biopharmaceutical, Inc. for Clinical Development of Novel Human Monoclonal Antiviral Antibody GlobeNewswire

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. It produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. The company also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. It serves biotechnology and pharmaceutical companies. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Ziebell Mark R	V. P., General Counsel	Jan 10	Sale	21.58	351	7,574	7,775	Jan 11 08:22 PM
Green Nicholas Stewart	President & CEO	Jan 10	Sale	21.58	3,214	69,357	25,468	Jan 11 08:21 PM
Hart Daniel R	Chief Financial Officer	Jan 10	Sale	21.58	877	18,925	27,976	Jan 11 08:22 PM
Ziebell Mark R	V. P., General Counsel	Jan 03	Option Exercise	12.74	20,675	263,476	21,675	Jan 05 07:56 PM
Hancock Richard B	Director	Jan 03	Option Exercise	4.53	5,000	22,650	40,200	Jan 05 07:53 PM
Hart Daniel R	Chief Financial Officer	Jan 03	Option Exercise	5.66	500	2,830	27,833	Jan 05 07:54 PM
Hancock Richard B	Director	Jan 03	Sale	27.53	5,000	137,644	35,200	Jan 05 07:53 PM
Hart Daniel R	Chief Financial Officer	Jan 03	Sale	29.07	500	14,535	27,333	Jan 05 07:54 PM
Ziebell Mark R	V. P., General Counsel	Jan 03	Sale	27.65	20,675	571,672	7,429	Jan 05 07:56 PM
Ziebell Mark R	V. P., General Counsel	Dec 27	Sale	30.27	6,829	206,689	7,429	Dec 29 07:23 PM
Ziebell Mark R	V. P., General Counsel	Dec 15	Option Exercise	3.29	6,429	21,151	20,687	Dec 16 09:36 PM
Ziebell Mark R	V. P., General Counsel	Dec 15	Sale	24.57	6,429	157,945	14,258	Dec 16 09:36 PM
Hancock Richard B	Director	Dec 01	Option Exercise	4.53	5,000	22,650	37,821	Dec 03 07:12 PM
Hancock Richard B	Director	Dec 01	Sale	30.90	5,000	154,509	32,821	Dec 03 07:12 PM
Hancock Richard B	Director	Nov 15	Option Exercise	4.53	13	59	37,821	Nov 17 07:29 PM
Hancock Richard B	Director	Nov 15	Sale	32.47	5,000	162,333	32,821	Nov 17 07:29 PM
Ziebell Mark R	V. P., General Counsel	Oct 11	Sale	22.37	349	7,808	14,258	Oct 12 05:38 PM
Green Nicholas Stewart	President & CEO	Oct 11	Sale	22.37	2,786	62,325	22,639	Oct 12 05:36 PM
Hart Daniel R	Chief Financial Officer	Oct 11	Sale	22.37	760	17,002	26,863	Oct 12 05:36 PM
Green Nicholas Stewart	President & CEO	Aug 02	Sale	25.56	18,701	477,998	19,852	Aug 03 08:17 PM
Ziebell Mark R	V. P., General Counsel	Jul 12	Sale	25.61	7,207	184,574	13,911	Jul 13 09:40 PM
Hart Daniel R	Chief Financial Officer	Jul 12	Sale	25.61	5,409	138,528	26,103	Jul 13 09:39 PM
Bamforth Mark R	Director	Mar 17	Buy	18.18	126,000	2,290,680	126,000	Mar 19 05:25 PM
Bamforth Mark R	Director	Mar 17	Sale	18.18	26,000	472,680	0	Mar 19 05:25 PM
Bamforth Mark R	Director	Mar 17	Sale	18.18	100,000	1,818,000	0	Mar 19 05:25 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience